Sitemap - 2014 - The California Stem Cell Report
California Stem Cell Report Goes Dark for a Couple of Weeks
North Korea, Sony and California Stem Cells
Former California Stem Cell CEO Zach Hall on Conflicts of Interest and Last Week's CIRM Board Voting
Eleven Percent Stock Price Drop for StemCells, Inc., on Bad News From California Stem Cell Agency
Stanford Pulls Its $10.9 Million Alpha Stem Cell Clinic Application
San Francisco Business Times: CIRM 2.0 is 'Business-Friendly,' 'All-Out Charge' for Stem Cell Cures
California Stem Cell Agency Press Release on its $50 Million, Fast-Track Plan
California Stem Cell Agency Concludes Meeting
California Launches $50 Million, Fast-Track Stem Cell Drive
California Stem Cell Agency Opens Board Meeting in Berkeley
California Stem Cell Agency Cancels $19 Million Award to StemCells, Inc.
New President and Organizational Tea Leaves from the California Stem Cell Agency
Stay on Top of California Stem Cell Research: $50 Million Fast-Track Program Up for Action Tomorrow
CIRM 2.0 -- California's New Urgency for Stem Cell Therapies
California Stem Cell Agency Overhauls Grant Review Conflict Rules; Secrecy Remains
'Radical' Improvements Coming at California Stem Cell Agency
California Stem Cell Speed-Up: $50 Million for New, Rapid-Action Program
A Public Mystery at the $3 Billion California Stem Cell Agency
California Stem Cell Research: Juggling Safety and Speed
Bubble Babies, Cures and California's Stem Cell Agency
Birthday Party for California's 10-year-old Stem Cell Research Program
10th Anniversary Media Event Tomorrow in Los Angeles for California Stem Cell Agency
A Look at Spinal Cord Injury Treatments from California's Stem Cell Agency
California's Grand, $3 Billion Stem Cell Experiment: An Evaluation at Age 10
Ten Year Performance of Stem Cell Agency: Top Execs' Comments
The California Stem Cell Agency Numbers
Comments From the First President of the California Stem Cell Agency
CIRM Board Member Sheehy on Stem Cell Agency Performance
Former California Stem Cell Board Member Shestack Comments on the Agency's Record
CIRM Board Member Prieto on 10-year Performance of Stem Cell Agency
Comments From a Former Communications Director at CIRM
A CIRM Performance Perspective from Chief Staff Person on Oversight Panel
Ben Kaplan of Prop. 71 Campaign on Performance of Stem Cell Agency
Patient Advocate Roman Reed on Stem Cell Agency Record
Venture Capitalist Kathy LaPorte Named to California Stem Cell Agency Board
BS and Ebola, Hype and Stem Cells
Researcher Takahashi Honored as Stem Cell Person of the Year
WARF, Oatmeal and the Patenting of Life
Judicial Activism, WARF and Embryonic Stem Cell Patents
'Wipe This Thing Off the Books:' More Coverage of WARF Patent Challenge
U.S. Supreme Court Action Being Sought in Major Human Embryonic Stem Cell Patent Case
$55 Million California Investment: First Patient Receives Viacyte Diabetes Device
Text of Letter by Ellen Feigal on Her Resignation
A Top Exec Departs from California Stem Cell Agency
California's Alpha Stem Cell Clinics Garner Little News Coverage
Today's California Stem Cell Meeting Concludes
More than $9 Million Approved for California Stem Cell Training Programs
$34 Million Stem Cell Effort: California Kicks Off Its Alpha Clinic Global Leadership Plan
Alpha Clinic Applications Now Being Considered by California Stem Cell Agency
Directors of the California Stem Cell Begin Los Angeles Meeting
Upcoming: Live Coverage on Alpha Stem Cell Clinics, Training at State Colleges
California's Alpha Stem Cell Clinic Plan Hits Budget Buzz Saw
California's $40 Million Alpha Clinic Round: Appeals Filed by Two Rejected Applicants
California Stem Cells, College Football and Success
No Appeals Filed Yet in California's $44 Million Alpha Stem Cell Clinic Round
California to Spend Up to $44 Million for Ambitious Alpha Stem Cell Clinic Plan
Prieto: Cost of Stem Cell Therapy Could Be 'Pretty Good Bargain'
Rosy Outlooks, Stem Cell Therapy and Stunning Costs
Twenty-six Nominated for 2014 Stem Cell Person of the Year Award
UC Irvine Mounts a New Stem Cell Research Blog
California's 'Bridges' Stem Cell Effort Hailed Again
Stem Cell Training Ending at California State Colleges?
ViaCyte: Stem Cell Diabetes Therapy 'Not Possible' Without California Taxpayer Cash
California Stem Cell Meeting Concludes; Links to Stories
Revolving Door Policy Tightened at California Stem Cell Agency
CIRM Press Release on Viacyte Award on Diabetes
California Bets $55 Million on 'Teabag' Diabetes Treatment
California Stem Meeting Begins in Berkeley
Coverage of California Stem Cell Meeting, Plus an Ohio Participation Possibility
San Diego's Viacyte Scoring Again with State Funding; Total Now Hits $55 Million
Tightening the Revolving Door at the California Stem Cell Agency
California's New $200 Million Stem Cell Spark
Asterias Stock Price Jumps Nearly 13 Percent Today Following hESC Therapy News
California's Stem Cell Trial for Spinal Cord Injury Moves Forward
Earthquakes and Scientific Research: California's Exposure to Damage
Stem Cell Blowback on the Ice Bucket Challenge
California Edges Forward with $39 Million Stem Cell Diabetes Effort
'De-risking' Stem Cell Therapy with Government Cash and Assistance
$40 Million California Stem Cell Genomics Agreement Signed; A Checkered Past
Another Perspective on the Trounson Flap: Columnist Lists It as Example of 'Possible Corruption'
The New, Official Life Expectancy of the California Stem Cell Agency
California Stem Cell Agency and the Revolving Door: A Need for More Safeguards
Los Angeles Times: Flawed Investigation Magnifies California Stem Cell Scandal
A USC Researcher's Perspective on the Grant Round Involving StemCells, Inc.
California Stem Cell Agency Scores on Early Coverage of Today's Trounson Story
Law Firm Memo on Trounson Investigation
Limited Trounson Investigation Shows No Evidence of Illegal Conflicts
California Stem Cell Agency Directors Conclude Meeting
$1.2 Million for UC Stem Cell Researchers
$5 Million Sliced from California's Ambitious Alpha Stem Cell Clinic Program
CIRM Says No Ilegality in Trouson Affair
Trounson Appointment Comments Begin CIRM Directors Meeting
Coming Up: Live Coverage of Today's California Stem Cell Meeting
A Brief Look at the $12 Million California Stem Cell Bridging Program
California Stem Cell Agency Director Prieto Defends Agency in Trounson Affair
Fallout From the Trounson Affair: A Taint on the California Stem Cell Agency
Cloaking Informed Consent in Clinical Trials: A California Stem Cell Case
Coming Up: Live Coverage of Thursday's California Stem Cell Board Meeting
California Stem Cell CEO Randy Mills on Focus and Four-Part Tests
Verastem Bid for Nearly $10 Million from California Nixed
Scripps Confirms Marletta's Plan to Leave as President
Scripps Research President Resigns Following Financial Problems at the Institute
California's Far-Reaching Alpha Stem Cell Clinic Plan Likely to Take a Hit
Creating Critical Mass at a California Stem Cell Consortium
Los Angeles Times: California Stem Cell Agency Rife with Conflicts and Unrealistic Expectations
California-funded Stem Cell Diabetes Treatment Edges Forward
StemCells, Inc., Says Patient Endangerment Charges Lack Merit
California Lawsuit Charges StemCells, Inc., with Putting Patients at Risk
A Nature Post Mortem on the Scripps-USC deal and Faculty Rebellion
California Stem Cell Agency to Alter $70 Million Alpha Clinic Proposal
More California Stem Cell Cash Likely for UC Irvine and UCLA
The Trounson Affair and its Financial Fallout
The Stem Cell Take on the World Cup: Chalk Up One for California
California Stem Cell Conflict Case Covered by Los Angeles Times
Biopolitical Times: Trounson-Weissman-StemCells, Inc., Affair is 'Shameful'
Scripps-USC Deal is Dead; Cash Problems Remain
Watchdog Says Trounson-StemCells, Inc., Connection Casts 'Shadow' Over California Stem Cell Agency
Hope and Home Runs: Nature and the Chron on the California Stem Effort
Disillusionment Cited by Scripps Researchers: No on Marletta and USC
Scripps' Top Faculty Wants Marletta Removed as President
Scripps-USC Update: $21 Million Scripps Deficit, Talks at Standstill
Expectations, Ballyhoo and Stem Cell Research
Hype and Hope: Illuminating the Reality of Stem Cell Treatments
Hillary Backs California Stem Cell Agency
California Stem Cell Agency Cites "Real Progress" on Calimmune's HIV Clinical Trial
Safety, Safety, Safety Should be No. 1 Job in Research Labs
USC Dangling $600 Million Lure for Scripps
Burrill's Appearance Scrubbed at Big Biotech Convention
UC San Diego Says Alliance with Scripps is Not Out of the Question
Tweeting the Elusive Stem Cell: A Canadian Study
California Biotech Guru Steven Burrill in 'Deep Yogurt'
New California Stem Cell CEO and his Criteria for Handing Out Cash
California's Trounson Wants to 'Shame' the 'Malefactors' of Stem Cell Medicine
USC and Scripps: A Looming Scientific Hookup?
Scientific Journals: A Case of 21st Century Dinosaurs?
California Stem Cell Directors Okay Tight, $17 Million Budget
A Nearly $1 Million Award, the California Stem Cell Agency and the Revolving Door
Stem Cells and Revolving Doors: The California Experience
Stanford's $40 Million Stem Cell Genomics Award Still Hanging Fire
WARF Triumphs in Latest Chapter of hESC Patent Challenge
California's $70 Million Alpha Stem Cell Clinic Project Runs Into Roadblock
Stem Cell Parsimony: California's New Stem Cell CEO Has Sharp Budget Knife
Sparse News Coverage This Morning of California Stem Cell Agency Action
CIRM Press Release on Today's Meeting and the Asterias Award
California Stem Cell Agency Approves $14 Million for Landmark hESC Clinical Trial
Text of the CIRM Review Summary of the Asterias hESC Clinical Trial Proposal
Lunch Break for California Stem Cell Directors
Researchers Seek to Overturn Negative Decisions by California Stem Cell Agency
California Spending $16.2 Million to Lure Stem Cell Scientists
California Stem Cell Researcher Recruitment Program Narrowly Survives
UC San Francisco and UC Davis Seek Millions for Recruitment of Scientists
Samuelson Resigns from California Stem Cell Agency Board
California Stem Cell Directors Open Meeting This Moning
Check This Web Site Tomorrow for Results of the California Stem Cell Agency Meeting
Results Heralded in Asterias hESC Clinical Trial
Asterias-Geron hESC Trial and Funding Reported in The Scientist
Where California's Stem Cell Spending is Going: Less Than a Half-Billion Left
$37 Million Slated for California Stem Cell Research
Next Action on Stem Cell Agency Budget on June 5
Major Step Forward on hESC Stem Cell Treatment for Spinal Cord Injury
Art Caplan on Fake Stem Cell Research: 'Off-the-Rails Syndrome?'
'Immortal' Stem Cells and Informed Consent in California
Capricor and California Stem Cell Agency Say All is Well With $27 Million Investment
Trounson Calls for Closer Ties Between Biotech Industry and Academic Research
CIRM 2.0, Randy Mills and Crystallization
Randy Mills: Stepping into a $3 Billion California Adventure
$17.9 Million California Stem Cell Spending Plan to be Scrutinized by New CEO
New Home for the California Stem Cell Agency? A Million-Dollar-Plus Matter
Chasing the Sun and Stem Cells From San Diego
California Stem Cell Agency Budget Up 10.5 Percent
Recent Reader Comments on Randy Miller and SF Chron Editorial
Randy Mills and His $640 Million California Stem Cell Experience
New California Stem Cell CEO Begins Work May 15
San Francisco Chronicle: California Stem Cell Agency 'Hasn't Lived up to Hype'
CIRM 2.0 and Randy Mills: Crystallizing a 'Tidal Shift' at the California Stem Cell Agency?
'As Soon as Mills Sat Down' -- CIRM Chairman on the Stem Cell Agency's New CEO
The New California Stem Cell CEO on Change and Accomplishments
Media Coverage of California's New Stem Cell CEO: Mills, Prochymal and Fresh Eyes
Former Osiris President Chosen as New CEO at California's Stem Cell Agency
Osiris CEO Moving to California Stem Cell Agency
California Stem Cell CEO Decision Still Up in the Air
$40 Million Stem Cell Genomics Award: Details Still Being Worked Out
Closed-Door Session Begins for Selection of New CEO for California Stem Cell Agency
California Stem Cell Agency Fires Up New Print/Online Endeavor
Picking a New Prez: Finalists for California Stem Cell Agency Post Coming from Private Sector
Post-Mortem on NIH and its Stem Cell Center Action
Genetic Anthropologist is New Honcho for California Stem Cell Agency Web Site
California Stem Cell Directors Nearing Decision on New CEO and Salary
NIH Action on Stem Cells: More Than 'Bureaucratic Bungling'
California Stem Cell CEO Search: Three to Four Candidates Remain, Fewer Tomorrow
$124 Million Deal for Keirstead's California Stem Cell, Inc.
Strangling Science: Antiquated System Wastes Billions, Costs Lives
Rao Joins New York Stem Cell Foundation
California Stem Cell CEO Search: Rao Out, Closed-Door Meeting Next Week
California's $40 Million Stem Cell Genomics Award Still Hanging Fire
The Long Odds Story of Stem Cell Research
Sunlight, Stem Cells and Feathers
The Boom in Privatized Science and the California Stem Cell Agency
Stem Cell Agency Directors Adjourn Until the End of May
California Stem Cell Directors Reject Conflict Charge on $13 Million Heart Research Proposal
$13 Million Heart Disease Application Up
Link to Approval of $72 Million for Commercialization of Stem Cell Research
Only $402 Million Left for California's Stem Cell Agency
California Approves $72 Million for Stem Cell Commercialization
Briefing on Stem Cell Portfolio
California Stem Cell Directors Open Meeting
Conflict of Interest Charge On California Stem Cell Agenda Today
Cedar-Sinai's Marban Files Appeal on $13 Million Heart Research Application
California Stem Cell Agency Reviews Its Response to Blue Ribbon Recommendations for Major Changes
Live Coverage of Tomorrow's California Stem Cell Board Meeting
The California Stem Cell Agency and Death by Power Point
Nine-year Veteran of California Stem Cell Agency Board Resigns
Critiquing the California Stem Cell Story: 'Continuums' vs. Cures
Japanese and California Stem Cell Affairs: An Opportunity to Make a Connection
Science and Blogging: A STAP Stem Cell Case Study
Craig Venter's "Road to the Cure" Stem Cell Venture
Sangamo and the California Stem Cell Agency: Good News for Both
$145 Million Bond Sale Next Month for California Stem Cell Agency
$72 Million for Commercial Stem Cell Therapies?
$40 Million California Genomics Award: Missing Names of Conflicted Reviewers Disclosed
Robert Klein, the California Stem Cell Agency and a $5 Billion Proposal
Board Counsel at California Stem Cell Agency Engaged in Examination of $40 Million Genomics Award
California Stem Cell Agency Shies Away from a $200 Million Possibility
California's $40 Million Stem Cell Genomics Award: Irregularities, Complaints and Integrity
California's Stem Cell Genomics Award: Text of Critique of Award Process
California Stem Cell Director Marcy Feit Leaves ValleyCare CEO Post
California's $70 Million Alpha Stem Cell Clinic Competition Ratchets Up
A Question of Orthodoxy: Would California Have Funded Vacanti?
Moderate Media Coverage of Stem Cell Agency and Genomics Award
Stanford Consortium Wins $40 Million to Create Stem Cell Genomics Center
Genomics Center Discussion Begins
California's Stem Cell Directors Back at Work
California Stem Cell Directors Working Through Lunch
$27 Million Approved for Basic Stem Cell Research in California
Stem Cell Ethics to be Examined in March
$21 Million of Basic Research Being Discussed by Stem Cell Agency
Conflicts Listed in Upcoming Voting in California's $40 Million Genomics Round
A Reading List for California's $40 Million Stem Cell Genomics Round
New CEO for California Stem Cell Agency in May
California Stem Cell Agency Opens Meeting to Discuss $40 Million Genomics Proposals
California Stem Cell Agency Withholds Key Information in $40 Million Genomics Proposals
Tracking the Evolution of the Stem Cell Genomics Applicants
Upcoming: Live and Complete Coverage of Tomorrow's $80 Million Stem Cell Meeting
Goldberg Departs from California Stem Cell Board; Panetta and Miller Join
$21 Million Likely for California's Basic Stem Cell Research
California's Stem Cell CEO Search: Dangling a 16-page Lure
Inside Stem Cell HQ: A Look at the Tiny Staff
California's $40 Million Genomics Awards: Stem Cell Agency Defends its Review Practices
California's $40 Million Genomics Round and Conflicts of Interest
California's Stem Cell Genomics Round Receives National News Attention
Alan Trounson's Opaque Messages, Genomics and $40 Million
Sacramento Bee: California Stem Cell Agency Betting Big on Genomics
California's $40 Million Genomics Round: Charges of Unfairness, Factual Error and More
Stanford Genomics Consortium Likely Winner in $33 Million Stem Cell Agency Project
California's Stem Cell Genomics Awards: An Untidy Affair
Jerry Brown: California Leads the Way on Stem Cell Research
California Stem Cell Agency to Hand Out $80 Million for Stem Cell, Genomics Research
CEO Search at California Stem Cell Agency: Board Discussions Set for Late This Month
Big Sangamo Deal for California Stem Cell Agency with an Asterisk
Changes Made in Tobacco Tax/Stem Cell Proposed Ballot Measure
Text of Tobacco Tax Initiative to be Posted on this Web Site
Tobacco Taxes and Stem Cells: Backers Still Not Talking, Questions Raised
Nine Years on the California Stem Trail: A Look Behind the Curtain
Irv Weissman and Reader Comment
Stem Cell Agency Financing Proposal a Mystery to Some
Tobacco Tax Looms as Financial Rescue for California Stem Cell Agency
California Gov. Brown's State Stem Cell Spending Figures
Knoepfler and Capricor Score Big This Week
Big Pharma's J&J Buys Into California Stem Cell Therapy Research for Heart Disease
Bloomberg Reports on the WARF hESC Patent Challenge